<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04404374</url>
  </required_header>
  <id_info>
    <org_study_id>SE TUKEB: 254/2017</org_study_id>
    <nct_id>NCT04404374</nct_id>
  </id_info>
  <brief_title>Treatment of Periodontal Intrabony Defects With A-PRF+ or EMD</brief_title>
  <official_title>Efficacy of a New-generation Platelet-rich Fibrin vs. Enamel Matrix Derivatives in the Treatment of Periodontal Intrabony Defects : a Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Semmelweis University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Semmelweis University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this randomized clinical trial was to clinically evaluate and compare the healing
      of intrabony defects after treatment with advanced platelet-rich fibrin (A-PRF+) to enamel
      matrix derivatives (EMD) in periodontitis patients.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 27, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Periodontal clinical parameters</measure>
    <time_frame>Change from baseline after 6 month and after 12 month</time_frame>
    <description>With a calibrated periodontal probe we are examining the changes of periodontal probing depth (PPD) and gingival recession (GR) after surgical procedure, the two parameters are used to determine the clinical attachment level (CAL).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Periodontal Diseases</condition>
  <arm_group>
    <arm_group_label>A-PRF</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Advanced Platelet-Rich Fibrin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EMD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Enamel Matrix Derivatives</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>A-PRF/EMD</intervention_name>
    <description>Comparing healing effect of an autologous and a xenogenic product</description>
    <arm_group_label>A-PRF</arm_group_label>
    <arm_group_label>EMD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  no systemic diseases that could influence the outcome of the therapy, a good level of
             oral hygiene, he presence of a 2-, 3-, or combined 2-3-wall intrabony defect with a
             defect angle of 20-40 (+/- 5) degrees, with a minimum PPD of 6 mm and intrabony
             component of a minimum 4 mm as detected on radiographs, no smoking

        Exclusion Criteria:

          -  systemic diseases that could influence the outcome of the therapy, poor oral hygiene,
             smoking, horizontal bone loss
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ferenc Dr.DÅ‘ri, professor</last_name>
    <role>Study Director</role>
    <affiliation>Semmelweis University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Semmelweis University, Department of Periodontology</name>
      <address>
        <city>Budapest</city>
        <zip>1088</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 19, 2020</study_first_submitted>
  <study_first_submitted_qc>May 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 27, 2020</study_first_posted>
  <last_update_submitted>May 21, 2020</last_update_submitted>
  <last_update_submitted_qc>May 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Semmelweis University</investigator_affiliation>
    <investigator_full_name>Boroka Csifo-Nagy</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Intrabony Defects</keyword>
  <keyword>New-Generation Platelet-Rich Fibrin</keyword>
  <keyword>Enamel Matrix Derivatives</keyword>
  <keyword>Periodontal Regeneration</keyword>
  <keyword>EMD</keyword>
  <keyword>A-PRF+</keyword>
  <keyword>Advanced Platelet-Rich Fibrin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontal Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

